Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors

Published:2019-11 Issue:11 Volume:26 Page:1586-1593.e3
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Chu Jennifer,Zhang Wenhan,Cencic Regina,Devine William G.,Beglov Dmitri,Henkel Thomas,Brown Lauren E.,Vajda Sandor,Porco John A.,Pelletier Jerry

Funder

Canadian Institutes of Health Research

NIH

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference29 articles.

1. The ATP-dependent interaction of eukaryotic initiation factors with mRNA;Abramson;J. Biol. Chem.,1987

2. Targeting the translation machinery in cancer;Bhat;Nat. Rev. Drug Discov.,2015

3. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation;Bordeleau;Proc. Natl. Acad. Sci. U S A,2005

4. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model;Bordeleau;J. Clin. Invest.,2008

5. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies;Boussemart;Nature,2014

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the role of PIK3R1 in cancer: A comprehensive review of regulatory signaling and therapeutic implications;Seminars in Cancer Biology;2024-11

2. Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis;Antiviral Research;2024-10

3. DMDA-PatA mediates RNA sequence-selective translation repression by anchoring eIF4A and DDX3 to GNG motifs;Nature Communications;2024-09-02

4. Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas;Scientific Reports;2024-08-20

5. Identification of Rocaglate Acyl Sulfamides as Selective Inhibitors of Glioblastoma Stem Cells;ACS Central Science;2024-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3